Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

Completed · Phase 2

Conditions studied: Neoplastic Syndrome

In brief

RATIONALE: Drugs used in chemotherapy, such as tazarotene, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying topical tazarotene to see how well it works in treating patients with basal cell skin cancer and basal cell nevus syndrome on the face.

Key facts

Study ID

NCT00489086

Run by

UCSF Benioff Children's Hospital Oakland

People needed

36

Starts

2004-07-01

Expected to finish

2012-06-01

Last updated by the study team

2020-10-29

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Children's Hospital and Research Center Oakland — Oakland, California, United States
• Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.